Niquitin Freshmint (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Niquitin Freshmint, is a nicotine replacement therapy presented as an oral formulation for oromucosal use. It treats nicotine dependence and aids smoking cessation in adults who wish to quit tobacco. GNH USA supplies Niquitin Freshmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin Freshmint is a nicotine replacement product used within the smoking cessation pathway. - Smoking cessation: assists adults in quitting tobacco by reducing withdrawal symptoms and cravings. - Nicotine dependence: provides controlled nicotine to lessen cravings during cessation attempts.

Common side effects are generally mild and related to the route of administration. Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: transient discomfort or dryness. - Nausea: occasional feeling of queasiness after use. - Headache: mild headache during initial days of therapy. Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain: unexpected thoracic discomfort. - Severe mouth ulceration: persistent ulcer that does not heal.

Before using Niquitin Freshmint, consider the following precautions. - Assess cardiovascular status: evaluate patient history of heart disease before initiating therapy. - Avoid use in recent myocardial infarction: contraindicated in patients with a recent heart attack. - Do not combine with other nicotine products: risk of nicotine overdose. - Monitor for signs of nicotine toxicity: watch for nausea, vomiting, rapid heartbeat, or dizziness. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Niquitin Freshmint may interact with other medicines; review the following. Major Interactions (Avoid): - Monoamine oxidase inhibitors: increased risk of hypertensive crisis. - Other nicotine replacement products: risk of nicotine overdose. - CYP2A6 inhibitors: may raise systemic nicotine levels. Moderate Interactions (Monitor Closely): - Alcohol: may enhance nicotine's cardiovascular effects. - Caffeine: may increase jitteriness and palpitations.